Found 36 matching trials
Effect of Time-Restricted Feeding on Fat Loss and Cardiometabolic Risk Factors in Overweight Adults NA Time-restricted feeding (TRF) is a novel type of intermittent fasting that ...
Show More Location
UAB Weight Loss Medicine Clinic
Learn More & Join Trial
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners N/A This trial studies the day-to-day stress, social support, and health lifest...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2 NA Introduction: In late 2019, a novel human coronavirus was detected in Wuhan...
Show More Location
Centro de Salud "La Milagrosa" Soria Sur
Learn More & Join Trial
Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly PHASE2 The purpose of the study is to evaluate the effect of a naturally occurring...
Show More Location
Johns Hopkins Bayview Medical Center
Learn More & Join Trial
Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) PHASE3 This purpose of this study is to determine the efficacy and safety of a gra...
Show More Location
Multiple Locations
Learn More & Join Trial
Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder PHASE2 The purpose of this study is to determine whether the drug prazosin is effe...
Show More Location
VA Puget Sound Health Care System
Learn More & Join Trial
Prazosin Alcohol Dependence IVR Study PHASE4 This double-blind placebo controlled pilot trial will test the hypothesis t...
Show More Location
VA Puget Sound Health Care System
Learn More & Join Trial
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder PHASE2 Obsessive-compulsive disorder (OCD) affects 2-3% of the population and lead...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) PHASE3 The purpose of the study is to investigate the efficacy and safety of a gra...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3) PHASE2 This is a two-part study that will determine, if: 1) the combination of rid...
Show More Location
Multiple Locations
Learn More & Join Trial